Weight-loss drug Wegovy cuts heart attack, stroke risk by 20%, study says

A new study shows the popular weight loss drug Wegovy can also reduce the risk of a heart attack or stroke by 20%. That's according to a not yet peer-reviewed clinical trial performed by drugmaker Novo Nordisk that studied more than 17,000 non-diabetic adults with heart disease who were obese or overweight. Cardiologist Dr. Ernst von Schwarz joins CBS News to discuss the significance of the findings.

Click for more information.

You Might Also Enjoy...

5 Symptoms That Suggest You May Have a Thyroid Disorder

Do you feel exhausted most of the time? Do you find it difficult to control your weight? Is “brain fog” an ongoing problem? If you answered yes to these questions, a thyroid disorder could be the culprit. Learn more here.

5 Signs You May Be Suffering from Low Testosterone

Are routine concerns like a sluggish metabolism, reduced muscle mass, weight gain, and low libido a normal part of male aging, or are they signs of diminished testosterone levels? Learn more about this common and highly treatable problem.

Tirzepatide and Semaglutide: Learn About These New Weapons in the Weight Loss Battle

Beyond traditional diets: Discover the next-generation solutions revolutionizing weight management. Weight loss injectables offer hope to the many Americans struggling with their weight.

Can Medical Marijuana Help My Digestive Disorder?

If you live with a persistent digestive disorder, front-line treatments may not always provide effective relief. Learn how medical marijuana works to ease hard-to-manage gastrointestinal symptoms — and find out how it can help you.

New weight loss options!

DONT WAIT! WE HAVE GENERIC OZEMPIC AND MOUNJARO, (SEMAGLUTIDE AND TIRZEPATIDE) IN STOCK!

Urgent Care

We offer same-day, walk-in and urgent care appointments. Skip the lines and the phone calls, and just come in for evaluation for flu symptoms, back pain, work notes, COVID tests...